Several small studies have previously observed an elevated abundance of antennary fucosylation in the total plasma N-glycome in patients with colorectal cancer [34] as well as in haptoglobin of patients with pancreatic [35], hepatic [36], and prostatic [37] cancers compared to controls, highlighting the importance of fucosylation across several malignancies [38]. The gene discussed is HP; the disease is cancer.